INS and diabetes mellitus: Since GLP‐1‐based drugs and sulfonylurea compounds are important insulin secretagogues and widely used clinically in diabetes, we studied the effect of BLX‐1002 on GLP‐1‐ and tolbutamide‐induced insulin secretion (Fig. 2).